首页> 美国卫生研究院文献>Journal of Arrhythmia >Differences in outcomes between oral anticoagulation new starters and switchers in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials

【2h】

Differences in outcomes between oral anticoagulation new starters and switchers in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials

机译：非瓣膜性心房颤动患者口服抗凝药新药和转换药的预后差异：AMADEUS和BOREALIS试验的汇总分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To explore differences in outcomes between dose‐adjusted vitamin K antagonists (VKAs) “new starters” and “switchers” in patients with nonvalvular atrial fibrillation (AF).

机译：探讨非瓣膜性心房颤动（AF）患者的剂量调整后的维生素K拮抗剂（VKA）“新药”和“转换药”之间的结局差异。

著录项

期刊名称 Journal of Arrhythmia
作者
Ying Bai; Alena Shantsila; Gregory Y. H. Lip;
展开▼
作者单位

展开▼
年(卷),期 2019(35),6
年度 2019
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
new starter; switcher; vitamin K antagonists;

机译：新药;切换剂;维生素K拮抗剂;

相似文献

外文文献
中文文献
专利

1. Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials [J] . Ying Bai, Alena Shantsila, Gregory Y. H. Lip Journal of arrhythmia. . 2019,第6期

机译：非瓣膜性心房颤动患者口服抗凝药“新药”和“转换药”结局的差异：AMADEUS和BOREALIS试验的汇总分析
2. Response to Letter Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Piccini Jonathan P., Stevens Susanna R., Chang YuChiao, Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：对有关“非瓣膜性房颤患者中风和全身性栓塞的预测指标：肾功能不全：ROCKET AF（Rivaroxaban每日一次，口服，直接因素）中的R（2）CHADS（2）指数的验证的答复Xa抑制与维生素K拮抗剂在房颤预防卒中和栓塞试验中的比较以及ATRIA（房颤的抗凝和危险因素）研究队列”
3. Letter by Apostolakis et al Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Apostolakis Stavros, Lane Deirdre A., Banerjee Amitava Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：Acostolakis等人关于文章的信，“肾功能障碍是非衰弱性心房颤动患者中风和全身栓塞的预测因子：验证R（2）牧草（2）指数在火箭AF中的指数（Rivaroxaban曾经每日，口服，与维生素K拮抗剂相比，直接因子XA抑制预防心房颤动中的中风和栓塞试验）和阿里亚（心房颤动的抗凝和危险因素）研究队列“
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial [O] . Ying Bai, Alena Shantsila, Gregory Y. H. Lip 2020

机译：抗凝性房颤患者肾功能改变的临床结局：BOREALIS试验的辅助分析
7. Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials [O] . Ying Bai, Alena Shantsila, Gregory Y. H. Lip 2019

机译：非血管性颤动患者口服抗凝“新启动”和“切换器”的结果差异：Amadeus和Borealis试验的汇总分析

Differences in outcomes between oral anticoagulation new starters and switchers in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials

摘要

著录项

相似文献

相关主题

期刊订阅